Alpenglow Teams Up with Virdx to Boost Prostate Cancer Diagnosis with Nvidia, AI Power

Alpenglow Biosciences and Virdx have entered a multiyear partnership to develop AI-powered tools that improve prostate cancer detection. Combining Alpenglow’s 3D pathology expertise with Virdx’s MRI-based technology and Nvidia’s GPU computing, the collaboration will accelerate research, enable large-scale clinical trials, and create a comprehensive 3D prostate tissue dataset using light-sheet microscopy.